rs2241745
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003749.3(IRS2):c.4012+11858G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.873 in 152,236 control chromosomes in the GnomAD database, including 58,105 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.87 ( 58105 hom., cov: 32)
Consequence
IRS2
NM_003749.3 intron
NM_003749.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.61
Publications
6 publications found
Genes affected
IRS2 (HGNC:6126): (insulin receptor substrate 2) This gene encodes the insulin receptor substrate 2, a cytoplasmic signaling molecule that mediates effects of insulin, insulin-like growth factor 1, and other cytokines by acting as a molecular adaptor between diverse receptor tyrosine kinases and downstream effectors. The product of this gene is phosphorylated by the insulin receptor tyrosine kinase upon receptor stimulation, as well as by an interleukin 4 receptor-associated kinase in response to IL4 treatment. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.904 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IRS2 | NM_003749.3 | c.4012+11858G>A | intron_variant | Intron 1 of 1 | ENST00000375856.5 | NP_003740.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| IRS2 | ENST00000375856.5 | c.4012+11858G>A | intron_variant | Intron 1 of 1 | 1 | NM_003749.3 | ENSP00000365016.3 |
Frequencies
GnomAD3 genomes AF: 0.873 AC: 132820AN: 152118Hom.: 58058 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
132820
AN:
152118
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.873 AC: 132922AN: 152236Hom.: 58105 Cov.: 32 AF XY: 0.873 AC XY: 64959AN XY: 74414 show subpopulations
GnomAD4 genome
AF:
AC:
132922
AN:
152236
Hom.:
Cov.:
32
AF XY:
AC XY:
64959
AN XY:
74414
show subpopulations
African (AFR)
AF:
AC:
37865
AN:
41550
American (AMR)
AF:
AC:
13818
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
3096
AN:
3472
East Asian (EAS)
AF:
AC:
3994
AN:
5138
South Asian (SAS)
AF:
AC:
3994
AN:
4824
European-Finnish (FIN)
AF:
AC:
9169
AN:
10604
Middle Eastern (MID)
AF:
AC:
268
AN:
294
European-Non Finnish (NFE)
AF:
AC:
58078
AN:
68022
Other (OTH)
AF:
AC:
1865
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
851
1702
2553
3404
4255
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
898
1796
2694
3592
4490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2828
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.